Literature DB >> 9228283

Antigen processing by proteasomes: insights into the molecular basis of crypticity.

H Djaballah1.   

Abstract

Eight to eleven amino acid residues are the sizes of predominant peptides found to be associated with MHC class I molecules. Proteasomes have been implicated in antigen processing and generation of such peptides. Advanced methodologies in peptide elution together with sequence determination have led to the characterisation of MHC class I binding motifs. More recently, screening of random peptide phage display libraries and synthetic combinatorial peptide libraries have also been successfully used. This has led to the development and use of predictive algorithms to screen antigens for potential CTL epitopes. Not all predicted epitopes will be generated in vivo and the emerging picture suggests differential presentation of predicted CTL epitopes ranging from cryptic to immunodominant. The scope of this review is to discuss antigen processing by proteasomes, and to put forward a hypothesis that the molecular basis of immunogenicity can be a function of proteasomal processing. This may explain how pathogens and tumours are able to escape immunosurveillance by altering sequences required by proteasomes for epitope generation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228283     DOI: 10.1023/a:1006808824631

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  42 in total

Review 1.  Covalent modification reactions are marking steps in protein turnover.

Authors:  E R Stadtman
Journal:  Biochemistry       Date:  1990-07-10       Impact factor: 3.162

Review 2.  Decrypting class I MHC-bound peptides with peptide libraries.

Authors:  K Udaka
Journal:  Trends Biochem Sci       Date:  1996-01       Impact factor: 13.807

3.  Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.

Authors:  T P Dick; T Ruppert; M Groettrup; P M Kloetzel; L Kuehn; U H Koszinowski; S Stevanović; H Schild; H G Rammensee
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

Review 4.  Surface hydrophobicity and intracellular degradation of proteins.

Authors:  P Bohley
Journal:  Biol Chem       Date:  1996 Jul-Aug       Impact factor: 3.915

5.  The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.

Authors:  G Niedermann; G King; S Butz; U Birsner; R Grimm; J Shabanowitz; D F Hunt; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 6.  Antigen processing and presentation by the class I major histocompatibility complex.

Authors:  I A York; K L Rock
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

7.  Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions.

Authors:  H Djaballah; A J Rivett
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

8.  Peptide binding and presentation by mouse CD1.

Authors:  A R Castaño; S Tangri; J E Miller; H R Holcombe; M R Jackson; W D Huse; M Kronenberg; P A Peterson
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

9.  Evidence that the nature of amino acid residues in the P3 position directs substrates to distinct catalytic sites of the pituitary multicatalytic proteinase complex (proteasome).

Authors:  C Cardozo; A Vinitsky; C Michaud; M Orlowski
Journal:  Biochemistry       Date:  1994-05-31       Impact factor: 3.162

10.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.

Authors:  M Orlowski; C Cardozo; C Michaud
Journal:  Biochemistry       Date:  1993-02-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.